Back to Search
DAVID KELSEN, MD
MD
Medical Oncology Physician
NPI: 1275504060Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
127093(NY)
Research & Publications (20)
S-1 adjuvant chemotherapy for advanced gastric cancer.
PMID 18521116·Nat Clin Pract Oncol·2008
8-other
Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer.
PMID 17704421·J Clin Oncol·2007
4-observational
Surrogate endpoints in assessment of new drugs in colorectal cancer.
PMID 10972363·Lancet·2000
8-other
Postoperative adjuvant chemoradiation therapy for patients with resected gastric cancer: intergroup 116.
PMID 11060322·J Clin Oncol·2000
8-other
Neoadjuvant therapy of squamous cell carcinoma of the esophagus.
PMID 10693243·Recent Results Cancer Res·2000
8-other
Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer.
PMID 19228527·J Am Coll Surg·2009
8-other
Randomized phase II trial evaluating two paclitaxel and cisplatin-containing chemoradiation regimens as adjuvant therapy in resected gastric cancer (RTOG-0114).
PMID 19273696·J Clin Oncol·2009
3-trial
G3139 (Genasense) in patients with advanced merkel cell carcinoma.
PMID 19307957·Am J Clin Oncol·2009
3-trial
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
PMID 19381079·Am J Clin Oncol·2009
3-trial
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer.
PMID 19451750·Pancreatology·2009
3-trial
Phase I trial of weekly cisplatin, irinotecan and paclitaxel in patients with advanced gastrointestinal cancer.
PMID 18956138·Invest New Drugs·2009
3-trial
Phase I study of weekly cisplatin, bolus fluorouracil and escalating doses of irinotecan in advanced solid tumors.
PMID 19219674·Cancer Invest·2009
3-trial
The Quality of Quality-of-Life and Cost-Effectiveness Analyses.
PMID 19259301·Gastrointest Cancer Res·2008
8-other
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer.
PMID 18270704·Cancer Chemother Pharmacol·2008
3-trial
Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
PMID 18360283·Am J Surg Pathol·2008
8-other
Phase II randomized trial of two nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113.
PMID 18574157·J Clin Oncol·2008
3-trial
A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors.
PMID 18927314·Clin Cancer Res·2008
3-trial
Pneumatosis intestinalis: a variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity.
PMID 17962908·Invest New Drugs·2008
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1275 YORK AVE
NEW YORK, NY 10021 - Phone
- (212) 639-2000
Quick Facts
- NPI
- 1275504060
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile